DUBLIN–(BUSINESS WIRE)–The “In Vitro Diagnostic Market Brief Update” report has been added to ResearchAndMarkets.com’s offering. What Major Trends are Affecting the Market Diagnostic test products have never been more important. This report is an update of the market for in vitro diagnostics products from the analysts to reflect the latest information as of Q4 2021. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Colorectal Cancer Screening Tests Market Analysis by Screening Test (Flexible Sigmoidoscopy, Stool-Based Tests, CT Colonography, Colonoscopy), by End User (Independent Diagnostic Labs, Hospitals), and by Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The global colorectal cancer screening tests market size is estimated to be USD 12,994 million in … [Read more…]

NeuroFront receives an exclusive option for an exclusive license to develop, commercialize and manufacture NRD.E1, Novaremed’s first-in-class, non-opioid investigational drug for the treatment of chronic neuropathic pain in Greater China and Singapore Novaremed is entitled to receive a total of over USD 130 million in option and exercise fees as well as development, regulatory and … [Read more…]

AUSTIN, Texas & PARIS–(BUSINESS WIRE)–DentalMonitoring has launched a breakthrough service for dental professionals and industry partners: the DM Intelligent Platform is now the only digital workflow which can interface and integrate with all dental digital solutions available on the market today. This industry-first accomplishment reinforces DentalMonitoring’s vision of making dentistry smarter, helping improve clinical outcomes … [Read more…]

IPH6401/SAR’514 is a BCMA-targeting NK cell engager using Sanofi’s proprietary CROSSODILE® multi-functional platform. It was developed jointly and benefits from the dual NK targeting of Innate’s ANKETTM proprietary platform Selection of IPH6401/SAR’514 triggers a €3M milestone payment to Innate MARSEILLE, France–(BUSINESS WIRE)–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) … [Read more…]

– Peking Union Medical College Hospital Primary Clinical Trial Site BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals Inc. (HKEX:1228), a China and US-based global biopharmaceutical company committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, announced that the first patient has been dosed in the CAN103 Phase 1/2 trial in … [Read more…]

BEIJING, China & TOKYO–(BUSINESS WIRE)–#CCR8–February 1st 2021, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”) entered a strategic collaboration with LiberoThera Co., Ltd (“LiberoThera”) to co-develop fully human GPCR antibodies using Biocytogen’s advanced antibody discovery platform based on fully human antibody RenMabTM mice combined with LiberoThera’s outstanding membrane antigen preparation technology. In around a year since the … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–#monkeypox–With the World Health Organization set to meet for the second time tomorrow to decide whether to declare monkeypox a Public Health Emergency of International Concern (PHEIC), AIDS Healthcare Foundation strongly urges the WHO to acknowledge the rapid, uncontrolled spread of the virus and declare it a pandemic. Monkeypox has spread to over … [Read more…]

OAKLAND, Calif.–(BUSINESS WIRE)–#CWCI–Proposals to cut the amount of time California workers’ compensation claims administrators have to investigate work-related injuries and determine employer liability may be easier said than done given existing statutory and regulatory time frames for the various steps within the process, many of which claims organizations do not control, according to a new … [Read more…]

BOULDER, Colo.–(BUSINESS WIRE)–$CLVS–First paragraph, second sentence of release should read: Clovis’ senior management will host a conference call and live audio webcast at 8:30am ET to discuss Clovis’ results and business outlook in greater detail. (instead of Clovis’ senior management will host a conference call and live audio webcast at 6:30am ET to discuss Clovis’ … [Read more…]